Deborah Ristvedt

1 week ago | ophthalmologytimes.com | Deborah Ristvedt |Sheryl Stevenson |Hattie Hayes

Author(s):,Glaucoma management is shifting toward earlier, drop-sparing interventions using sustained drug delivery and advanced laser technologies that improve outcomes and quality of life for both patients and physicians. Deb Ristvedt, DO, moderated a session titled Medications, Lasers, and Lifestyle, highlighting the rapid evolution of glaucoma treatment paradigms at the 2025 American Society of Cataract and Refractive Surgery annual meeting, held April 25 to 28 in Los Angeles, California.

1 month ago | optometrytimes.com | Melissa Tawa |Cecelia Koetting |Melissa Barnett |Deborah Ristvedt |Jordana Joy

The rustic landscape of Napa Valley hosted CRU 2025, which allowed optometrists and ophthalmologists to learn the latest in glaucoma, retina, and more. In between wine tastings, eye care providers had the chance to reflect on what they are taking back to their practices that is current, relevant, and useful. Melissa Tawa, OD, FAAO, highlighted what she learned about inherited retinal diseases at the conference.

1 month ago | optometrytimes.com | Deborah Ristvedt |Jordana Joy

March 31, 2025By Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California. Deborah Ristvedt, DO, from Vance Thompson Vision discusses the significant evolution of glaucoma treatment over the past decade. The presentation focuses on moving beyond traditional eye drop treatments to more proactive and patient-friendly interventional approaches. The key shift in glaucoma care is transitioning from a reactive to a preventative model.

Aug 31, 2024 | optometrytimes.com | Melissa Tawa |Deborah Ristvedt |Inder Singh |Arsham Sheybani

August 31, 2024By In this episode, four expert faculty talk about the importance of early diagnosis and treatment of thyroid eye disease. They discuss the differential diagnosis, screening tests, and the need for multidisciplinary management for these patients. Glaucoma remains a leading cause of irreversible blindness globally as progressive optic nerve damage leads to permanent vision loss.

Aug 1, 2024 | eyetube.net | Arsham Sheybani |Deborah Ristvedt

IOL Selection in Combination MIGS Procedures Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Deborah Ristvedt, DO Show Description + Deborah Ristvedt, DO, sits down with Arsham Sheybani, MD, and Iqbal Ike K. Ahmed, MD, FRCSC, to review her approach to lens selection in combination cataract surgery and MIGS. She emphasizes that doctors have an obligation to understand the most recent advances in technology to provide the best possible outcomes for patients.